Article info

other Versions

PDF
Consensus-based recommendations for the use of biosimilars to treat rheumatological diseases

Authors

  1. Correspondence to Professor Jonathan Kay, Division of Rheumatology, Department of Medicine, UMass Memorial Medical Center and University of Massachusetts Medical School, Worcester, MA 01605, USA; jonathan.kay{at}umassmemorial.org
View Full Text

Citation

Kay J, Schoels MM, Dörner T on behalf of the Task Force on the Use of Biosimilars to Treat Rheumatological Diseases, et al
Consensus-based recommendations for the use of biosimilars to treat rheumatological diseases

Publication history

  • Received 15 June 2017
  • Revised 20 July 2017
  • Accepted 12 August 2017
  • Published in print 5 September 2017.
  • Published first 2 September 2017.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.